A METHOD FOR RAPID GENERATION OF MODEL INTESTINAL BARRIERS IN VITRO
Nikulin SV1'2 H Poloznikov AA1, Sakharov DA2
1 National Research University Higher School of Economics, Moscow, Russia
2 SRC Bioclinicum, Moscow, Russia
To increase the efficiency of drug development process, it is important to improve performance of preclinical experiments. A major drawback of the currently used in vitro intestinal barrier models is that it takes a significant time to obtain functional enterocyte monolayers with formed tight junctions. In this work, we have optimized various parameters such as cell density and different coatings, for a more rapid and efficient producing Caco-2 cell monolayers suitable for further experiments. In vivo microscopy and impedance spectroscopy were used to monitor cells state under various conditions. To determine possible biological mechanisms affected by exposure to various protein substrates, the transcriptomic analysis was applied. It was shown that collagen IV coating of the cell growth substrate significantly increased the rate of proliferation and migration of Caco-2 cells. This effect allows forming a functional monolayer of epithelial cells with tight junctions within 24 hours. Optimally, the initial cell density should be 90,000 to 200,000 cells/cm2. It was observed that collagen IV was poorly expressed by Caco-2 cells while the collagen IV receptor was expressed at a relatively high level in these cells. Laminin-332, another basement membrane component, was found to have no significant effect on times of formation of functional epithelial monolayers. Thus, using the optimal parameters determined in this study allows to significantly improve efficiency of using the in vitro intestinal barrier models.
Keywords: collagen IV barrier tissues, laminin-332, TEER, extracellular matrix, Caco-2, impedance spectroscopy Funding: the study was supported by the Russian Science Foundation, protocol № 16-19-10597.
Author contribution: Nikulin SV — cell culture work, preparation of samples for transcriptome analysis, data analysis, manuscript preparation; Poloznikov AA — analysis of transcriptome data, manuscript preparation; Sakharov DA — supervision, manuscript preparation.
Compliance with ethical standards: the study complies with the 1964 Helsinki Declaration and its later amendments.
1X1 Correspondence should be addressed: Sergey V. Nikulin Vavilova, 7, Moscow, 117321; nikulin.c.b@gmail.com
Received: 09.11.2020 Accepted: 03.12.2020 Published online: 15.12.2020
DOI: 10.24075/brsmu.2020.077
МЕТОДИКА УСКОРЕННОГО ПОЛУЧЕНИЯ МОДЕЛЬНЫХ КИШЕЧНЫХ БАРЬЕРОВ IN VITRO
С. В. Никулин1-2 А. А. Полозников1, Д. А. Сахаров2
1 Национальный исследовательский университет «Высшая школа экономики», Москва, Россия
2 Научно-технический центр «БиоКлиникум», Москва, Россия
Для повышения эффективности разработки лекарственных препаратов необходимо увеличивать производительность экспериментов, проводимых на доклинической стадии. Существенным недостатком используемых на сегодняшний день in vitro моделей кишечного барьера является скорость образования функционального монослоя энтероцитов со сформировавшимися плотными контактами. Целью работы было провести комплексный подбор параметров (различные покрытия и плотность клеток) для быстрого и эффективного получения пригодного к проведению экспериментов монослоя клеток Caco-2. Для оценки состояния культуры клеток при различных условиях применяли прижизненную микроскопию и импедансную спектроскопию. Для определения возможного биологического механизма действия различных белковых субстратов на энтероциты использовали транскриптомный анализ. Показано, что покрытие субстрата для роста клеток коллагеном IV существенно повышает скорость пролиферации и миграции клеток линии Caco-2. Такое воздействие позволяет в течение 24 ч сформировать функциональный монослой эпителиальных клеток с плотными контактами. С целью получения пригодного для проведения экспериментов кишечного барьера in vitro в течение 24 ч начальная плотность клеток должна лежать в диапазоне 90-200 тыс. клеток на 1 см2. Обнаружено, что клетки Caco-2 слабо экспрессируют коллаген IV при этом рецепторы к коллагену IV у данных клеток экспрессированы на достаточно высоком уровне. Показано также, что еще один компонент базальной мембраны ламинин 332 не оказывает заметного влияния на скорость формирования функционального монослоя эпителиальных клеток. Таким образом, в работе были определены оптимальные параметры, позволяющие существенно повысить производительность экспериментов с in vitro моделями кишки.
Ключевые слова: коллаген IV барьерная ткань, ламинин 332, TEER, внеклеточный матрикс, Caco-2, импедансная спектроскопия
Финансирование: работа выполнена при финансовой поддержке Российского научного фонда (проект № 16-19-10597).
Вклад авторов: С. В. Никулин — культуральная работа, подготовка образцов для анализа транскриптома, анализ данных, написание статьи; А. А. Полозников — анализ транскриптомных данных, написание статьи; Д. А. Сахаров — организация исследования, написание статьи.
Соблюдение этических стандартов: все образцы для исследования были получены с соблюдением принципов и правил Хельсинкской декларации.
[Ж1 Для корреспонденции: Сергей Вячеславович Никулин ул. Вавилова, д. 7, г. Москва, 117321; nikulin.c.b@gmail.com
Статья получена: 09.11.2020 Статья принята к печати: 03.12.2020 Опубликована онлайн: 15.12.2020 DOI: 10.24075/vrgmu.2020.077
Intestine is an important organ where food is digested, nutrients and drugs are absorbed into the blood, and interaction of microorganisms with host cells occurs. One of the main intestine functions is the barrier function. Intestinal barrier dysfunction has been implicated in numerous health conditions including inflammatory and autoimmune diseases [1]. Cancer chemotherapies often lead to gut barrier dysfunction [2].
The pathways for transporting molecules through the intestinal barrier include active transport, passive diffusion through the cell membrane, and passive diffusion through the intercellular spaces in between epithelial cells. Epithelial tight junctions are the key structures regulating paracellular trafficking of molecules [3]. Tight junctions are multi-protein complexes located close to the apical surfaces of the epithelial cells
and consisting of different cytoplasmic and transmembrane proteins such as occludin and claudins. Due to dynamic changes of tight junctions, intestinal permeability can change rapidly [4]. The tight junction protein complexes are dynamically modulated by various signaling molecules such as kinases (c-Src, c-Yes, etc.) and cytokines (PHOa, interferron y, etc.) [5]. Since tight junctions play an important role in the functioning of the intestine both in normal and in pathology, it is crucial to develop appropriate in vitro models to evaluate various effects on tight junctions [6, 7].
There are a few different techniques for measuring the paracellular permeability reflecting the integrity of tight junctions. In particular, measurements of molecular marker concentrations on both sides of the barrier are widely used [8, 9]. However, this method is time-consuming and not easy to use. Alternatively, transepithelial electrical resistance (TEER) can be used to monitor changes in epithelial cell culture integrity [10]. Using this quantitative technique takes researchers less time and is well suitable for the high-throughput screening; TEER measurement accuracy can be increased by applying impedance spectroscopy [11, 12].
Currently, Caco-2 cell line is widely used to model the intestinal barrier in vitro [13]. The Caco-2 cells were originally derived from a colon adenocarcinoma — the cells turned out to be able to spontaneously differentiate into a monolayer of cells with many properties typical of the small intestine epithelium [14, 15]. Caco-2 cells are known to form tight junctions as they grow and differentiate, and the cell density of their tight junctions is higher than in normal colon [14, 15]. This makes Caco-2 cell line a valuable transport model system for studying tight junction processes. However, for a wider application of this cell model, it is necessary to improve experiment performance. This can be partially achieved by cell culture automation, e.g. using microfluidic chips [16-18] however, it would be very helpful to optimize cultivation conditions to make it possible to have ready for use cell models more rapidly.
Our study was aimed at determining the optimal cultivation conditions for Caco-2 cells that would allow obtaining functional cell monolayers with tight junctions as quickly as possible.
METHODS
Caco-2 cells were obtained from the Institute of Cytology of the Russian Academy of Sciences (Russia). The cells were cultured in MEM (Gibco; USA) supplemented with 20% fetal bovine serum (Gibco; USA) and 1% penicillin-streptomycin (Gibco; USA). Cells were maintained at 37 °C in an incubator with 5% CO2. Subcultivation was performed every 2 or 3 days according to the standard procedure using a trypsin EDTA solution (PanEco; Russia). Cell counts were performed using Automated Countess Cell Counter (Gibco; USA) according to the manufacturer's recommendations.
Cells were seeded onto 1.0 pm pore-size polyester inserts (PET) HTS Transwell-96 (Corning; US). Before seeding, a part of membranes was coated with laminin-332 (BioLamina; Sweden) and another part was coated with type IV collagen (Imtek; Russia): 30 pl of proten in DPBS solution with 10 pg/ml concentration was added to each membrane insert. Then, 96-well plates with membrane inserts were incubated at 4 °C for 24 h. After incubation, protein solutions were removed from all wells, and each well was washed 3 times with 100 pl of DPBS solution.
Right before cell seeding, HTS membrane inserts were filled with culture medium (50 pl into the upper chamber and 235 pl in the lower chamber) and incubated in a cell incubator
for one hour. Then different quantities of cells were added to each membrane insert (6,250, 12,500 or 25,000 cells per well) to 50 pl of the culture medium to achieve initial cell density of 43,700, 87,400 and 174,800 cells per cm2, respectively. Each experiment was carried out in three repeats. 96-well plates with membrane inserts were incubated in a cell incubator throughout the experiment.
To determine TEER values in 24 h and 48 h from the onset of the experiment, impedance spectra measurements were made using an impedance spectrometry system (BioClinicum; Russia) and original electrodes (BioClinicum; Russia). TEER values were calculated following the previously described equivalent electrical circuit [19] using CEISA Impedance fitting (BioClinicum; Russia). Statistical analysis of obtained data was carried out using the programming language R 4.0 with the integrated development environment RStudio 1.1 (RStudio PBC; USA). To assess the statistical significance of the observed TEER differences, we used a three-factor (substrate type, initial cell density, and time from the onset of the experiment) Analysis of Variance (ANOVA) Tukey-adjusted for multiple comparisons. Differences were considered significant at p < 0.05.
To obtain microscopic images of Caco-2 cells on various substrates, some of the wells in 96-well plates (Corning; US) was coated with laminin-332 (BioLamina; Sweden) and type IV collagen (Imtek; Russia) using the protocol similar to membrane inserts coating. 50 pl of protein solution per well was used for coating. Each well was then loaded with 100 pL of cell suspension in a complete culture medium with concentration of 100,000 and 200,000 cells per 1 ml (corresponding to the initial cell densities 31,300 and 62,600 per cm2). The plates were further incubated in a cell incubator. Microscopic images were obtained using PrimoVert inverted microscope (Carl Zeiss; Germany).
To obtain fully differentiated Caco-2 cells, culturing was carried out according to the procedure described in [11, 19]. Analysis of gene expression levels in differentiated and undifferentiated Caco-2 cells was carried out using microchips GeneChip Human Genome 1.0 ST (Affymetrix; USA) [20]. Cells were lysed with QIAzol lysis buffer (Qiagen; Germany). Total RNA was isolated using miRNeasy Mini Kit (Qiagen; Germany) according to the manufacturer's protocol. Concentration of isolated total RNA was measured using NanoDrop 1000 spectrophotometer (Thermo Fisher Scientific; USA). RNA quality was assessed using the Experion system (Bio-Rad; USA). For hybridization on microchips, 500 ng of each RNA sample was used. The experiment was carried out in three repeats.
The results were processed using TAC 4.0 software (Thermo Fisher Scientific; USA). The statistical significance of differences in expression levels between differentiated and undifferentiated Caco-2 cells was assessed by single factor variance analysis (ANOVA) adjusted with Benjamini-Hochberg. The significance threshold was 0.05. Genes with an expression level less than 6.0 on the Affymetrix logarithmic scale were considered not expressed.
RESULTS
Based on TEER measurements (Fig.1) for membrane inserts made 24 h after the cell seeding, TEER was shown to increase as initial cell density increased. E.g., for uncoated control membrane inserts, TEER values were found to be about 118 Q.cm2 higher for the maximum initial cell density compared to the minimum initial cell density (p < 0.001). No significant differences were found between intermediate and minimum
initial cell densities (p = 1). Similar results were observed for the laminin-332 coated wells. In case of laminin-332 coating, no significant TEER differences were found as compared to uncoated control wells for all tested initial cell densities (p = 1).
In case of type IV collagen coating, the results differed significantly. Considerable differences were observed between the minimum tested initial cell density of 43,700 cells per cm2 and 87,400 cells per cm2 (an increase of 147 Q.cm2; p < 0.001), as well as between the minimum tested initial cell density of 43,700 cells per cm2 and 174,800 cells per cm2 (an increase of 208 Q.cm2; p < 0,001). Thus, in case of type IV collagen coating, the dependence of TEER values on initial cell densities was more significant. For the initial densities 87,400 cells per cm2 and 174,800 cells per cm2, a strong increase in TEER (188 Q.cm2 and 142 Q.cm2, respectively) was also found in type IV collagen coated wells as compared to control polyester wells (p < 0,001 in both cases).
After 48 h from the beginning of the experiment, TEER values in the uncoated control wells increased significantly for the 87,400 initial cell density and for the 174,800 initial cell density compared to the measurements taken 24 h after cell seeding (202 Q.cm2 and 110 Q.cm2, respectively; p < 0.001 and p = 0.002, respectively). At the same time, in case of minimal 43,700 initial cell density, there was no significant difference between TEER values for 48 h measurements and 24 h measurements (p = 1).
In the case of laminin-332 coating, similar dynamics was observed comparing 48 h vs. 24 h TEER values: for 43,700 cells/cm2 initial density, no significant difference was found (p = 0.1); for 87,400 cells/cm2 initial density, TEER values significantly increased by 165 Q.cm2 (p < 0.001) however, for the 174,800 cells/cm2 initial density, the observed growth by 83 Q.cm2 was not statistically significant (p = 1). On the other hand, in case of type IV collagen coated wells, a significant TEER increase (175 Q.cm2) was reported in case of the minimum initial cell density only (p < 0.001) while no significant differences between related 48 h and 24 h measurements were found for 87,400 cells/cm2 and 174,800 cells/cm2 initial densities (p = 0.2 and p = 1, respectively).
Interestingly, for uncoated wells and for laminin-332 coated wells, 48 h TEER values were still dependent on the initial cell densities. In case of uncoated wells, 48 h TEER values were
A COL IV LAM 332 PET
higher as compared to the 43,700 cells/cm2 initial density for both 87,400 initial density (172 Q.cm2; p < 0.001) and 174,800 cells/cm2 initial density (188 Q.cm2; p < 0,001). Similar results were obtained in case of laminin-332 coating. At the same time, 48 h TEER values in the wells coated with type IV collagen were not dependent significantly on the initial cell density (p = 1 in all cases) and were more than 200 Q.cm2.
In order to evaluate the effect of type IV collagen/ laminin-332 substrate coating on cell morphology and growth rate, live-cell imaging of Caco-2 cells was performed in 24 hours after cell seeding (Fig. 2). It turned out that for control uncoated wells and laminin-332 coated wells, 100% confluence was not achieved at the considered initial cell densities. However, in case of type IV collagen coating, about 80% of surface was covered in wells with 31,300 cells/cm2 initial density, and a monolayer was formed in wells with 62,600 cells/cm2 initial density. In type IV collagen coated wells, an increased amounts of elongated spindle shaped cells were observed compared with control wells and laminin-332 wells.
Transcriptomic analysis showed that in both differentiated and undifferentiated Caco-2 cells, expression of all type IV collagen chains was at a relatively low level (< 7 according to Affymetrix logarithmic scale) (see Table). Moreover, in the process of cell differentiation a slight decrease in expression of COL4A1 and COL4A6 genes was observed.
Integrins a1 p1 and a2^1 are known to be the main receptors of type IV collagen [21]. Transcriptomic analysis showed that ITGB1 gene (p1-integrin chain) was expressed at a sufficiently high level in both differentiated and undifferentiated Caco-2 cells (10.0 and 10.1 in Affymetrix logarithmic scale respectively), and its expression did not significantly change during the process of differentiation (p = 0.4). ITGA1 gene (a1-chain integrin) was also expressed in both differentiated and undifferentiated Caco-2 cells (8.6 and 9.0 in Affymetrix logarithmic scale, respectively) however, its expression slightly decreased in differentiated cells (1.3 times lower; p = 0,002).
Similar results were obtained for ITGA2 gene (a2 integrin chain): the average expression values were 9.2 for differentiated cells and 9.5 for undifferentiated cells while a small 1.3 time decrease of expression in differentiated cells was statistically significant (p = 0,04).
B COL IV LAM 332 -■- PET
300
200
100
E
O
300
200
100
Cell density, per (cm-2)
Cell density, per (cm-2)
Fig. 1. TEER values In 24 hours (A) and 48 hours (B) from the onset of experiment. Statistically significant differences of coated membranes compared to uncoated membranes are marked with * COL IV — type IV collagen; LAM 332 — laminin-332; PET — uncoated
0
0
Initial cell density 31,300 cells/cm-2
Initial cell density 62,600 cells/cm2
PS 24 h
COL IV 24 h
LAM 332 24 h
Fig. 2. Caco-2 monolayer Images In 24 h (scale segment bar Is 200 pm) COL IV — type IV collagen; LAM 332 — lamlnln-332; PET — uncoated
DISCUSSION
The experiment showed that type IV collagen was the most effective substrate significantly accelerating the process of formation of functional epithelial intestinal barrier. Some chains of type IV collagen (a1, a2, a5 and a6) are known to be involved in formation and development of the intestine, and the proteins can be synthesized in both epithelial and mesenchymal cells [22]. Based on the results of transcriptomic analysis, Caco-2 cells cannot sufficiently synthesize type IV collagen while at all stages, the cells express receptors for type IV collagen which indicates that type IV collagen may have effect on the cell processes.
Based on the obtained cell images, it can be concluded that type IV collagen promotes both proliferation and migration of Caco-2 cells. To date, an extended data has been accumulated
showing that type IV collagen stimulates both adhesion and migration of Caco-2 cells [23-25]. Type IV collagen is also known to stimulate proliferation of other epithelial cell types [26, 27]. Thus, the obtained results are well consistent with the data available from earlier studies.
Effect of type IV collagen on Caco-2 monolayer TEER values has already been studied, and it was found that a few days after cell seeding, TEER values were significantly higher in the wells coated with type IV collagen however, the dynamics of TEER changes during the first few days of cell culturing was not determined [28]. In the present study, it was shown that type IV collagen affects not only the TEER values but also the time periods when TEER values (about 200 Q.cm2) [9] become sufficient for barrier model experiments — it can be really achieved within 24 h period. The obtained results can be easily
Table. Type IV collagen expression levels In differentiated and undifferentiated Caco-2 cells (Affymetrix logarithmic scale)
Gene Average expression level In differentiated Caco-2 cells Average expression level In undifferentiated Caco-2 cells Difference FDR p
COL4A1 6.15 6.39 -1.18 0.0235
COL4A2 6.7 6.74 -1.02 0.3724
COL4A3 5.92 5.96 -1.03 0.3166
COL4A4 5.66 5.67 -1.01 0.5068
COL4A5 6.54 6.74 -1.15 0.0904
COL4A6 5.91 6.29 -1.3 0.0302
applied both to other static in vitro models of barrier tissues and to dynamic microfluidic systems [29, 30].
CONCLUSION
In our experiments, we found that using the type IV collagen coated substrate for cell growth significantly increased the rate of proliferation and migration of Caco-2 cells. This made it possible to obtain functional monolayers of epithelial cells with tight junctions contacts within 24 hours. The optimal initial cell densities were also determined. For obtaining an
intestinal barrier model in vitro during 24-hour period, the initial cell density should be 90,000 to 200,000 cells per cm2. Type IV collagen was found to be poorly expressed by Caco-2 cells while the expression levels of type IV collagen receptor proteins were relatively high in the cells. Another basement membrane component laminin-332 was shown to have no significant effect on the rate of formation of functional epithelial cell monolayers.
The findings can be used to further improve the performance of experiments involving in vitro intestinal barrier models both in static conditions and in microfluidic systems.
References
1. Turner JR. Intestinal mucosal barrier function in health and disease. Nat Rev Immunol [Internet]. 2009 Nov; 9 (11): 799-809. Available from: http://dx.doi.org/10.1038/nri2653.
2. Bajic JE, Johnston IN, Howarth GS, Hutchinson MR. From the Bottom-Up: Chemotherapy and Gut-Brain Axis Dysregulation. Front Behav Neurosci [Internet]. 2018 May 22; 12 (May): 1-16. Available from: https://www.frontiersin.org/article/10.3389/ fnbeh.2018.00104/full.
3. Lee SH. Intestinal Permeability Regulation by Tight Junction: Implication on Inflammatory Bowel Diseases. Intest Res [Internet]. 2015; 13 (1): 11. Available from: http://irjournal.org/journal/view. php?doi=10.5217/ir.2015.13.1.11.
4. Varadarajan S, Stephenson RE, Miller AL. Multiscale dynamics of tight junction remodeling. J Cell Sci [Internet]. 2019 Nov 15; 132 (22): jcs229286. Available from: http://jcs.biologists.org/lookup/ doi/10.1242/jcs.229286.
5. Chelakkot C, Ghim J, Ryu SH. Mechanisms regulating intestinal barrier integrity and its pathological implications. Exp Mol Med [Internet]. 2018 Aug 16; 50 (8): 103. Available from: http://dx.doi. org/10.1038/s12276-018-0126-x.
6. Peters MF, Landry T, Pin C, Maratea K, Dick C, Wagoner MP, et al. Human 3D Gastrointestinal Microtissue Barrier Function As a Predictor of Drug-Induced Diarrhea. Toxicol Sci [Internet]. 2019 Mar 1; 168 (1): 3-17. Available from: https://academic.oup.com/ toxsci/article/168/1/3/5145097.
7. Hashimoto Y, Tachibana K, Krug SM, Kunisawa J, Fromm M, Kondoh M. Potential for Tight Junction Protein-Directed Drug Development Using Claudin Binders and Angubindin-1. Int J Mol Sci [Internet]. 2019 Aug 17; 20 (16): 4016. Available from: https:// www.mdpi.com/1422-0067/20/16/4016.
8. Hidalgo IJ, Raub TJ, Borchardt RT. Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology [Internet]. 1989 Mar; 96 (3): 736-49. Available from: http://linkinghub.elsevier.com/ retrieve/pii/S0016508589800721.
9. Hubatsch I, Ragnarsson EGE, Artursson P. Determination of drug permeability and prediction of drug absorption in Caco-2 monolayers. Nat Protoc [Internet]. 2007 Sep; 2 (9): 2111-9. Available from: http://www.nature.com/doifinder/10.1038/ nprot.2007.303.
10. Srinivasan B, Kolli AR, Esch MB, Abaci HE, Shuler ML, Hickman JJ.
TEER Measurement Techniques for In Vitro Barrier Model Systems. J Lab Autom [Internet]. 2015 Apr; 20 (2): 107-26. Available from: http://journals.sagepub.com/doi/10.1177/2211068214561025.
11. Nikulin SV, Gerasimenko TN, Shilin SA, Zakharova GS, Gazizov IN, Poloznikov AA, et al. Application of Impedance Spectroscopy for the Control of the Integrity of In Vitro Models of Barrier Tissues. Bull Exp Biol Med [Internet]. 2019 Feb 19; 166 (4): 512-6. Available from: http://link.springer.com/10.1007/s10517-019-04384-5.
12. Gerasimenko T, Nikulin S, Zakharova G, Poloznikov A, Petrov V, Baranova A, et al. Impedance Spectroscopy as a Tool for Monitoring Performance in 3D Models of Epithelial Tissues. Front Bioeng Biotechnol [Internet]. 2019; 7: 474. Available from: http:// www.ncbi.nlm.nih.gov/pubmed/32039179.
13. Shah P, Jogani V, Bagchi T, Misra A. Role of Caco-2 Cell Monolayers in Prediction of Intestinal Drug Absorption. Biotechnol Prog [Internet]. 2006 Feb 3; 22 (1): 186-98. Available from: http:// doi.wiley.com/10.1021/bp050208u.
14. Hilgendorf C, Spahn-Langguth H, Regärdh CG, Lipka E, Amidon GL, Langguth P. Caco-2 versus Caco-2/HT29-MTX Co-cultured Cell Lines: Permeabilities Via Diffusion, Inside- and Outside-Directed Carrier-Mediated Transport. J Pharm Sci [Internet]. 2000 Jan; 89 (1): 63-75. Available from: https://linkinghub.elsevier.com/ retrieve/pii/S0022354916305408.
15. Artursson P, Palm K, Luthman K. Caco-2 monolayers in experimental and theoretical predictions of drug transport. Adv Drug Deliv Rev [Internet]. 2012 Dec; 64 (SUPPL.): 280-9. Available from: https://linkinghub.elsevier.com/retrieve/pii/ S0169409X12002657.
16. Sakharov D, Maltseva D, Knyazev E, Nikulin S, Poloznikov A, Shilin S, et al. Towards embedding Caco-2 model of gut interface in a microfluidic device to enable multi-organ models for systems biology. BMC Syst Biol [Internet]. 2019 Mar 5; 13 (Suppl 1): 19. Available from: https://bmcsystbiol.biomedcentral.com/ articles/10.1186/s12918-019-0686-y.
17. Mehling M, Tay S. Microfluidic cell culture. Curr Opin Biotechnol [Internet]. 2014 Feb; 25: 95-102. Available from: https:// linkinghub.elsevier.com/retrieve/pii/S0958166913006794.
18. Caicedo HH, Brady ST. Microfluidics: The Challenge Is to Bridge the Gap Instead of Looking for a "Killer App." Trends Biotechnol [Internet]. 2016; 34 (1): 1-3. Available from: http://dx.doi. org/10.1016/j.tibtech.2015.10.003.
19. Nikulin SV, Knyazev EN, Gerasimenko TN, Shilin SA, Gazizov IN, Zakharova GS, et al. Non-Invasive Evaluation of Extracellular Matrix Formation in the Intestinal Epithelium. Bull Exp Biol Med [Internet]. 2018 Nov 12; 166 (1): 35-8. Available from: http://link. springer.com/10.1007/s10517-018-4283-7.
20. Samatov TR, Senyavina NV, Galatenko VV, Trushkin EV, Tonevitskaya SA, Alexandrov DE, et al. Tumour-like druggable gene expression pattern of CaCo2 cells in microfluidic chip. Bio Chip J. 2016 Sep;10 (3): 215-20.
21. Khoshnoodi J, Pedchenko V, Hudson BG. Mammalian collagen IV. Microsc Res Tech [Internet]. 2008 May; 71 (5): 357-70. Available from: http://doi.wiley.com/10.1002/jemt.20564.
22. Simoneau A, Herring-Gillam FE, Vachon PH, Perreault N, Basora N, Bouatrouss Y, et al. Identification, distribution, and tissular origin of the a5(IV) and a6(IV) collagen chains in the developing human intestine. Dev Dyn [Internet]. 1998 Jul; 212 (3):437-47. Available from: https://onlinelibrary.wiley.com/doi/10.1002/(SICI)1097-0177(199807)212:3%3C437::AID-AJA11%3E3.0.C0;2-Y.
23. Basson MD, Modlin IM, Madri JA. Human enterocyte (Caco-2) migration is modulated in vitro by extracellular matrix composition and epidermal growth factor. J Clin Invest [Internet]. 1992 Jul 1; 90 (1): 15-23. Available from: http://www.jci.org/articles/view/115828.
24. Sanders MA, Basson MD. Collagen IV regulates Caco-2 cell spreading and p130Cas phosphorylation by FAK-dependent and FAK-independent pathways. Biol Chem [Internet]. 2008 Jan 1; 389 (1): 47-55. Available from: http://www.degruyter.com/view/j/ bchm.2008.389.issue-1/bc.2008.008/bc.2008.008.xml.
25. Sanders MA, Basson MD. Collagen IV regulates Caco-2 migration
and ERK activation via a 1 ß 1 - and a 2 ß 1 -integrin-dependent Src kinase activation. Am J Physiol Liver Physiol [Internet]. 2004 Apr; 286 (4): G547-57. Available from: https://www.physiology. org/doi/10.1152/ajpgi.00262.2003.
26. Matsuura-Hachiya Y, Arai KY, Muraguchi T, Sasaki T, Nishiyama T. Type IV collagen aggregates promote keratinocyte proliferation and formation of epidermal layer in human skin equivalents. Exp Dermatol [Internet]. 2018 May; 27 (5): 443-8. Available from: http://doi.wiley.com/10.1111/exd.13328.
27. Öhlund D, Franklin O, Lundberg E, Lundin C, Sund M. Type IV collagen stimulates pancreatic cancer cell proliferation, migration, and inhibits apoptosis through an autocrine loop. BMC Cancer [Internet]. 2013 Dec 26; 13 (1): 154. Available from: http://bmccancer.biomedcentral. com/articles/10.1186/1471-2407-13-154.
28. Vllasaliu D, Falcone FH, Stolnik S, Garnett M. Basement membrane influences intestinal epithelial cell growth and presents a barrier to the movement of macromolecules. Exp Cell Res [Internet]. 2014 Apr; 323 (1): 218-31. Available from: http://dx.doi.org/10.1016/j. yexcr.2014.02.022.
29. Maoz BM, Herland A, Henry OYF, Leineweber WD, Yadid M, Doyle J, et al. Organs-on-Chips with combined multi-electrode array and transepithelial electrical resistance measurement capabilities. Lab Chip [Internet]. 2017; 17 (13): 2294-302. Available from: http:// dx.doi.org/10.1039/C7LC00412E.
30. Kim HJ, Huh D, Hamilton G, Ingber DE. Human gut-on-a-chip inhabited by microbial flora that experiences intestinal peristalsislike motions and flow. Lab Chip [Internet]. 2012; 12 (12): 2165. Available from: http://xlink.rsc.org/?DOI=c2lc40074j.
Литература
1. Turner JR. Intestinal mucosal barrier function in health and disease. Nat Rev Immunol [Internet]. 2009 Nov; 9 (11): 799-809. Available from: http://dx.doi.org/10.1038/nri2653.
2. Bajic JE, Johnston IN, Howarth GS, Hutchinson MR. From the Bottom-Up: Chemotherapy and Gut-Brain Axis Dysregulation. Front Behav Neurosci [Internet]. 2018 May 22; 12 (May): 1-16. Available from: https://www.frontiersin.org/article/10.3389/ fnbeh.2018.00104/full.
3. Lee SH. Intestinal Permeability Regulation by Tight Junction: Implication on Inflammatory Bowel Diseases. Intest Res [Internet]. 2015; 13 (1): 11. Available from: http://irjournal.org/journal/view. php?doi=10.5217/ir.2015.13.1.11.
4. Varadarajan S, Stephenson RE, Miller AL. Multiscale dynamics of tight junction remodeling. J Cell Sci [Internet]. 2019 Nov 15; 132 (22): jcs229286. Available from: http://jcs.biologists.org/lookup/ doi/10.1242/jcs.229286.
5. Chelakkot C, Ghim J, Ryu SH. Mechanisms regulating intestinal barrier integrity and its pathological implications. Exp Mol Med [Internet]. 2018 Aug 16; 50 (8): 103. Available from: http://dx.doi. org/10.1038/s12276-018-0126-x.
6. Peters MF, Landry T, Pin C, Maratea K, Dick C, Wagoner MP, et al. Human 3D Gastrointestinal Microtissue Barrier Function As a Predictor of Drug-Induced Diarrhea. Toxicol Sci [Internet]. 2019 Mar 1; 168 (1): 3-17. Available from: https://academic.oup.com/ toxsci/article/168/1/3/5145097.
7. Hashimoto Y, Tachibana K, Krug SM, Kunisawa J, Fromm M, Kondoh M. Potential for Tight Junction Protein-Directed Drug Development Using Claudin Binders and Angubindin-1. Int J Mol Sci [Internet]. 2019 Aug 17; 20 (16): 4016. Available from: https:// www.mdpi.com/1422-0067/20/16/4016.
8. Hidalgo IJ, Raub TJ, Borchardt RT. Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology [Internet]. 1989 Mar; 96 (3): 736-49. Available from: http://linkinghub.elsevier.com/ retrieve/pii/S0016508589800721.
9. Hubatsch I, Ragnarsson EGE, Artursson P. Determination of drug permeability and prediction of drug absorption in Caco-2 monolayers. Nat Protoc [Internet]. 2007 Sep; 2 (9): 2111-9. Available from: http://www.nature.com/doifinder/10.1038/ nprot.2007.303.
10. Srinivasan B, Kolli AR, Esch MB, Abaci HE, Shuler ML, Hickman JJ. TEER Measurement Techniques for In Vitro Barrier Model Systems. J Lab Autom [Internet]. 2015 Apr; 20 (2): 107-26. Available from: http://journals.sagepub.com/doi/10.1177/2211068214561025.
11. Nikulin SV, Gerasimenko TN, Shilin SA, Zakharova GS, Gazizov IN, Poloznikov AA, et al. Application of Impedance Spectroscopy for the Control of the Integrity of In Vitro Models of Barrier Tissues. Bull Exp Biol Med [Internet]. 2019 Feb 19; 166 (4): 512-6. Available from: http://link.springer.com/10.1007/s10517-019-04384-5.
12. Gerasimenko T, Nikulin S, Zakharova G, Poloznikov A, Petrov V, Baranova A, et al. Impedance Spectroscopy as a Tool for Monitoring Performance in 3D Models of Epithelial Tissues. Front Bioeng Biotechnol [Internet]. 2019; 7: 474. Available from: http:// www.ncbi.nlm.nih.gov/pubmed/32039179.
13. Shah P, Jogani V, Bagchi T, Misra A. Role of Caco-2 Cell Monolayers in Prediction of Intestinal Drug Absorption. Biotechnol Prog [Internet]. 2006 Feb 3; 22 (1): 186-98. Available from: http:// doi.wiley.com/10.1021/bp050208u.
14. Hilgendorf C, Spahn-Langguth H, Regärdh CG, Lipka E, Amidon GL, Langguth P. Caco-2 versus Caco-2/HT29-MTX Co-cultured Cell Lines: Permeabilities Via Diffusion, Inside- and Outside-Directed Carrier-Mediated Transport. J Pharm Sci [Internet]. 2000 Jan; 89 (1): 63-75. Available from: https://linkinghub.elsevier.com/ retrieve/pii/S0022354916305408.
15. Artursson P, Palm K, Luthman K. Caco-2 monolayers in experimental and theoretical predictions of drug transport. Adv Drug Deliv Rev [Internet]. 2012 Dec; 64 (SUPPL.): 280-9. Available from: https://linkinghub.elsevier.com/retrieve/pii/ S0169409X12002657.
16. Sakharov D, Maltseva D, Knyazev E, Nikulin S, Poloznikov A, Shilin S, et al. Towards embedding Caco-2 model of gut interface in a microfluidic device to enable multi-organ models for systems biology. BMC Syst Biol [Internet]. 2019 Mar 5; 13 (Suppl 1): 19. Available from: https://bmcsystbiol.biomedcentral.com/ articles/10.1186/s12918-019-0686-y.
17. Mehling M, Tay S. Microfluidic cell culture. Curr Opin Biotechnol [Internet]. 2014 Feb; 25: 95-102. Available from: https:// linkinghub.elsevier.com/retrieve/pii/S0958166913006794.
18. Caicedo HH, Brady ST. Microfluidics: The Challenge Is to Bridge the Gap Instead of Looking for a "Killer App." Trends Biotechnol
[Internet]. 2016; 34 (1): 1-3. Available from: http://dx.doi. org/10.1016/j.tibtech.2015.10.003.
19. Nikulin SV, Knyazev EN, Gerasimenko TN, Shilin SA, Gazizov IN, Zakharova GS, et al. Non-Invasive Evaluation of Extracellular Matrix Formation in the Intestinal Epithelium. Bull Exp Biol Med [Internet]. 2018 Nov 12; 166 (1): 35-8. Available from: http://link. springer.com/10.1007/s10517-018-4283-7.
20. Samatov TR, Senyavina NV, Galatenko VV, Trushkin EV, Tonevitskaya SA, Alexandrov DE, et al. Tumour-like druggable gene expression pattern of CaCo2 cells in microfluidic chip. Bio Chip J. 2016 Sep;10 (3): 215-20.
21. Khoshnoodi J, Pedchenko V, Hudson BG. Mammalian collagen IV. Microsc Res Tech [Internet]. 2008 May; 71 (5): 357-70. Available from: http://doi.wiley.com/10.1002/jemt.20564.
22. Simoneau A, Herring-Gillam FE, Vachon PH, Perreault N, Basora N, Bouatrouss Y, et al. Identification, distribution, and tissular origin of the a5(IV) and a6(IV) collagen chains in the developing human intestine. Dev Dyn [Internet]. 1998 Jul; 212 (3):437-47. Available from: https://onlinelibrary.wiley.com/doi/10.1002/(SICI)1097-0177(199807)212:3%3C437::AID-AJA11%3E3.0.C0;2-Y.
23. Basson MD, Modlin IM, Madri JA. Human enterocyte (Caco-2) migration is modulated in vitro by extracellular matrix composition and epidermal growth factor. J Clin Invest [Internet]. 1992 Jul 1; 90 (1): 15-23. Available from: http://www.jci.org/articles/view/115828.
24. Sanders MA, Basson MD. Collagen IV regulates Caco-2 cell spreading and p130Cas phosphorylation by FAK-dependent and FAK-independent pathways. Biol Chem [Internet]. 2008 Jan 1; 389 (1): 47-55. Available from: http://www.degruyter.com/view/j/ bchm.2008.389.issue-1/bc.2008.008/bc.2008.008.xml.
25. Sanders MA, Basson MD. Collagen IV regulates Caco-2 migration and ERK activation via a 1 ß 1 - and a 2 ß 1 -integrin-dependent Src kinase activation. Am J Physiol Liver Physiol [Internet]. 2004 Apr; 286 (4): G547-57. Available from: https://www.physiology. org/doi/10.1152/ajpgi.00262.2003.
26. Matsuura-Hachiya Y, Arai KY, Muraguchi T, Sasaki T, Nishiyama T. Type IV collagen aggregates promote keratinocyte proliferation and formation of epidermal layer in human skin equivalents. Exp Dermatol [Internet]. 2018 May; 27 (5): 443-8. Available from: http://doi.wiley.com/10.1111/exd.13328.
27. Öhlund D, Franklin O, Lundberg E, Lundin C, Sund M. Type IV collagen stimulates pancreatic cancer cell proliferation, migration, and inhibits apoptosis through an autocrine loop. BMC Cancer [Internet]. 2013 Dec 26; 13 (1): 154. Available from: http://bmccancer.biomedcentral. com/articles/10.1186/1471-2407-13-154.
28. Vllasaliu D, Falcone FH, Stolnik S, Garnett M. Basement membrane influences intestinal epithelial cell growth and presents a barrier to the movement of macromolecules. Exp Cell Res [Internet]. 2014 Apr; 323 (1): 218-31. Available from: http://dx.doi.org/10.1016/]. yexcr.2014.02.022.
29. Maoz BM, Herland A, Henry OYF, Leineweber WD, Yadid M, Doyle J, et al. Organs-on-Chips with combined multi-electrode array and transepithelial electrical resistance measurement capabilities. Lab Chip [Internet]. 2017; 17 (13): 2294-302. Available from: http:// dx.doi.org/10.1039/C7LC00412E.
30. Kim HJ, Huh D, Hamilton G, Ingber DE. Human gut-on-a-chip inhabited by microbial flora that experiences intestinal peristalsislike motions and flow. Lab Chip [Internet]. 2012; 12 (12): 2165. Available from: http://xlink.rsc.org/?DOI=c2lc40074j.